To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 656.00 |
Bid | 656.00 |
Ask | 658.00 |
Change | 2.00 (0.31%) |
Volume | 50,634 |
Open | 658.00 |
High | 658.00 |
Low | 646.00 |
Prev. Close | 654.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 38.03m |
Market Capitalisation | £249.49m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 43 |
---|---|
Vol. Sold | 38,082 |
Sold Value | £248.74k |
Vol. Bought | 11,946 |
Bought Value | £78.25k |
PE Ratio | 39.07088 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.299% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
28-Mar-24 | 17:44:05 | 654.066 | 606 | Unknown* | 656.00 | 658.00 | 3,964 | O Ordinary Was reported as OTC |
28-Mar-24 | 16:35:25 | 656.00 | 4,770 | Sell* | 656.00 | 658.00 | 31.29k | UT Uncrossing Trade |
28-Mar-24 | 16:13:25 | 656.60 | 1,990 | Sell* | 656.00 | 660.00 | 13.07k | O Ordinary |
28-Mar-24 | 15:58:21 | 657.3461 | 3,543 | Sell* | 656.00 | 660.00 | 23.29k | O Ordinary |
28-Mar-24 | 15:42:20 | 657.8245 | 550 | Buy* | 652.00 | 660.00 | 3,618 | O Ordinary |
28-Mar-24 | 15:28:17 | 654.6962 | 760 | Sell* | 652.00 | 660.00 | 4,976 | O Ordinary |
28-Mar-24 | 15:19:40 | 654.6922 | 400 | Sell* | 652.00 | 660.00 | 2,619 | O Ordinary |
28-Mar-24 | 15:19:33 | 657.8245 | 400 | Buy* | 652.00 | 660.00 | 2,631 | O Ordinary |
28-Mar-24 | 14:20:33 | 654.6922 | 318 | Sell* | 652.00 | 660.00 | 2,082 | O Ordinary |
28-Mar-24 | 14:20:33 | 657.8245 | 1,010 | Buy* | 652.00 | 660.00 | 6,644 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |